Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10620808 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL5133813 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL5051917 | 0.94 | LMNA (0.59) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL5028006 | 0.94 | LMNA (0.59) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL5052085 | 0.94 | LMNA (0.59) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL756618 | 0.94 | LMNA (0.59) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL20239655 | 0.87 | LMNA (0.44) | LMNAL3MBTL1TDP1ALDH1A1NR1I2 | |
| Mannitol SCHEMBL23066399 | 0.83 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL2477078 | 0.83 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL2297640 | 0.83 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250213655-A1 | COMPOSITIONS AND METHODS OF USE | GENENTECH INC (US) | 2025-07-03 | — | — | US | claimed |
| CN-119950683-A | Implantable polymer depot for controlled sustained release of therapeutic agents | 铸造疗法股份有限公司 | 2025-05-09 | — | — | CN | claimed |
| WO-2025021320-A1 | RETINOL CONTAINING DAY CREAM | THE BOOTS COMPANY PLC (GB) | 2025-01-30 | — | — | WO | claimed |
| US-11883453-B2 | Formulation based on medicinal plant, or part or extract thereof, use of the formulation and product including said formulation | PHYTOPLENUS BIOATIVOS S.A (BR) | 2024-01-30 | — | — | US | claimed |
| EP-4301346-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF METFORMIN | ORION CORPORATION (FI) | 2024-01-10 | — | — | EP | claimed |
| CN-116327681-A | Gel formulations comprising substituted imidazo [1, 2-alpha ] pyridin-2-ylamine hydrochloride hydrate | 上海复旦张江生物医药股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| WO-2022184981-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF METFORMIN | ORION CORPORATION (FI) | 2022-09-09 | — | — | WO | claimed |
| CN-114652661-A | Liquid composition with anti-aging effect and application thereof in cosmetics | 启迪禾美生物科技(嘉兴)有限公司 | 2022-06-24 | — | — | CN | claimed |
| US-20220183964-A1 | IMPLANTABLE POLYMER DEPOTS FOR THE CONTROLLED, SUSTAINED RELEASE OF THERAPEUTIC AGENTS | FOUNDRY THERAPEUTICS, INC. | 2022-06-16 | — | — | US | claimed |
| EP-3952847-A1 | IMPLANTABLE POLYMER DEPOTS FOR THE CONTROLLED, SUSTAINED RELEASE OF THERAPEUTIC AGENTS | Foundry Therapeutics, Inc. (US) | 2022-02-16 | — | — | EP | claimed |
| CN-101312953-A | Sulfur-containing pharmacologically active compounds | JON PTY LTD (AU) | 2008-11-26 | — | — | CN | claimed |
| US-20080132563-A1 | 1-Thio-D-Glucitol Derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2008-06-05 | — | — | US | claimed |
| CN-101103013-A | 1-thio-D-glucitol derivatives | TAISHO PHARMACEUTICAL CO LTD (JP) | 2008-01-09 | — | — | CN | claimed |
| EP-1845095-A1 | 1-THIO-D-GLUCITOL DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2007-10-17 | — | — | EP | claimed |
| CN-1299668-C | Nanometer realgar solid dispersion and its preparation method | UNIV HUAZHONG SCIENCE TECH (CN) | 2007-02-14 | — | — | CN | claimed |
| CN-1245975-C | Medicinal composition for stabilizing delotadine in preparation | TIANJIN MEDICINE ACADEMY (CN) | 2006-03-22 | — | — | CN | claimed |
| CN-1552324-A | Medicinal composition for stabilizing delotadine in preparation | 天津药物研究院 | 2004-12-08 | — | — | CN | claimed |
| EP-1304048-B1 | Composition to reduce or quit smoking addiction | PERA IVO (US) | 2004-09-22 | — | — | EP | claimed |
| CN-1478486-A | Nanometer realgar solid dispersion and its preparation method | 华中科技大学 | 2004-03-03 | — | — | CN | claimed |
| US-4585844-A | BASIC COMONOMER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-04-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132563-A1 | 1-Thio-D-Glucitol Derivatives | SLC5A1, SLC5A2, SLC5A11 | LMNA 4616/4885L3MBTL1 1990/4885TDP1 1619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.